Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus.
prognostic factors
radical nephrectomy
renal cell cancer
tumor thrombus
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Aug 2021
27 Aug 2021
Historique:
received:
05
07
2021
revised:
21
08
2021
accepted:
25
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
epublish
Résumé
This study aimed to define patients with renal cell cancer and coexisting tumor thrombus in order to address concerns regarding survival and prognostic factors after radical surgery. Several prognostic factors for overall survival (OS) were assessed in patients treated surgically at five institutions from 2012 to 2018. Univariate and multivariate analyses were used to determine the independent risk factors of OS. A total of 142 patients were eligible for further analysis (mean age of 64.75 years, 56% males). Most patients presented with clear cell carcinoma (95%). The Mayo stage was predominantly 0-1 (88%). Distant visceral metastases at the time of diagnosis were present in 36 patients (25%), whereas nodal metastases were present in 24 patients (16.9%). During the follow-up period (mean of 32.5 months), the 3-year OS rate reached 68.2%. The majority of patients received no adjuvant treatment (
Identifiants
pubmed: 34501296
pii: jcm10173852
doi: 10.3390/jcm10173852
pmc: PMC8432091
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Warszawski Uniwersytet Medyczny
ID : Publication subsidy fund
Références
J Urol. 2007 May;177(5):1703-8
pubmed: 17437789
Urol Int. 2017;99(3):267-271
pubmed: 28253496
J Urol. 2017 Aug;198(2):281-288
pubmed: 28268170
Transl Oncol. 2017 Dec;10(6):949-955
pubmed: 29035731
World J Urol. 2014 Jun;32(3):581-9
pubmed: 24752606
Ann Vasc Surg. 2010 Nov;24(8):1089-93
pubmed: 20471214
Biomed Res Int. 2015;2015:163423
pubmed: 26421277
Eur Urol. 2011 Jan;59(1):120-7
pubmed: 20980095
World J Surg Oncol. 2015 Feb 04;13:14
pubmed: 25650039
Int Braz J Urol. 2013 May-Jun;39(3):353-63
pubmed: 23849567
Eur J Surg Oncol. 2015 Jul;41(7):941-52
pubmed: 25817982
BMC Cancer. 2019 Feb 13;19(1):144
pubmed: 30760245
J Clin Oncol. 2017 Dec 10;35(35):3895-3897
pubmed: 29068785
Eur Urol. 2011 Aug;60(2):358-65
pubmed: 21640483
Anaesthesia. 1995 Jul;50(7):658-9
pubmed: 7653772
Cancer Treat Rev. 2018 Sep;69:112-120
pubmed: 29960124
Eur Urol. 2009 Feb;55(2):452-9
pubmed: 18692951
J Surg Oncol. 2016 Nov;114(6):764-768
pubmed: 27562252
Int J Urol. 2017 Feb;24(2):102-109
pubmed: 28111837
BMC Cancer. 2013 Oct 02;13:447
pubmed: 24083566
Eur Urol Focus. 2016 Dec 15;2(6):601-607
pubmed: 28723491
Ther Adv Med Oncol. 2010 Jan;2(1):39-49
pubmed: 21789125
Oncology. 2001;61(1):10-5
pubmed: 11474242
J Urol. 2010 Sep;184(3):833-41; quiz 1235
pubmed: 20643450
Br J Urol. 1987 May;59(5):390-5
pubmed: 3594097
J Urol. 2007 Oct;178(4 Pt 1):1189-95; discussion 1195
pubmed: 17698087
Int J Urol. 2015 Jun;22(6):534-9
pubmed: 25808349
Indian J Surg Oncol. 2017 Mar;8(1):14-18
pubmed: 28127177
Surgery. 2016 Oct;160(4):915-923
pubmed: 27506867